1  clinical practice in nontoxic uninodular or multinodular goiter.

2 131)I to treat hyperthyroidism and euthyroid multinodular goiter.

3 ten display thyroid abnormalities, including multinodular goiter and follicular adenomas, and are at

4  situations for autonomous nodules and toxic multinodular goiter and remains a safe and effective tre

5 ith non-medullary thyroid carcinoma (TC) and multinodular goiter, before and after treatment with rad

6                                Treatment for multinodular goiter includes dietary iodine supplementat

7  with an inherited tumor syndrome, featuring multinodular goiter (MNG) and rare pediatric-onset lesio

8  of 123] vs 24.3% [70 of 288], P < .001) and multinodular goiter or thyroid nodule (40.7% [50 of 123]

9 land disease (OR, 7.63; 95% CI, 3.49-16.69), multinodular goiter or thyroid nodule (OR, 1.82; 95% CI,

10  hyperthyroidism (Graves disease, GD), toxic multinodular goiter (TMNG), and toxic thyroid adenoma (T

11 ractive thyroid gland (Graves disease, toxic multinodular goiter, toxic adenoma).

12 lian tumor susceptibility syndrome: familial multinodular goiter with schwannomatosis.FUNDINGCanadian